TargED Biopharmaceuticals

Utrecht, Netherlands · Founded 2018 · Privately Held (backing)

Developer of biopharmaceutical drugs intended to serve doctors and healthcare professionals to improve the treatment of thrombosis. TargED Biopharmaceuticals is based in Utrecht, Netherlands and was founded in 2018. Its last reported valuation was $50 million in Dec 2025. It has raised $72.2 million.

Last reported valuation
$50.0M
Oct 2026
Priced at
—
Total raised
$72.2M
Last round
—

Who backs TargED Biopharmaceuticals?

17 investors
InvestorType
European Innovation CouncilVenture capital
Andera PartnersPE / buyout
Utrecht HoldingsOther
Rotrip EuropeFamily office
BioGeneration Ventures—
Curie Capital—
European Innovation Council (Belgium)—
Fund+—
Gold Track—
Hadean Ventures—
+ 7 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

TargED Biopharmaceuticals investors

17 investors are on record for TargED Biopharmaceuticals, including European Innovation Council, Andera Partners, Utrecht Holdings and Rotrip Europe.

Free account
More of TargED Biopharmaceuticals with a free account
  • ·The complete investor list: 17 names
  • ·Watch TargED Biopharmaceuticals: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 17 firms already write checks for companies like TargED Biopharmaceuticals. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View